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As researchers involved in molecular biology, we are witnessing tremendous paradigm changes in a
time frame that becomes shorter and shorter. The epoch-making notion, originally put forward by
the central dogma of biology (Crick, 1970), that there is a unidirectional process and a privileged
level (genetic) of causality at which biological functions are determined, has already long and
strongly been challenged. It is in fact well recognised that multi-level causality with feedback
cycles among all former and newly identified biochemical levels (including small RNAs, epigenomic
changes) is a fundamental attribute of biological systems (Noble, 2012).
Yet, the focus shift from single reactions to transcriptomics, promoted by microarray first and
sequencers now, is already challenged by a novel, pressing offer from fast evolving technologies.
Indeed, the possibility to have a omic view on virtually all molecular layers (genomes, metagenomes,
transcriptomes, proteomes, epigenomes) pushes to integrate the study of systems at yet another
level of complexity, a run harmed, and not negligibly, by the difficulties in formatting, storing, and
reusing the deluge of data encompassing every level of biological organization.
In such a complex background, it is growingly acknowledged that tools and theoretical
frameworks that could help in combining and giving account for both the multi-level causation
scheme and the burden of data are still underdeveloped (Witzany and Baluska, 2012).
From these considerations, a novel, pressing request arises to design methodologies, approaches
and frameworks that allow for these data to be interpreted as a whole, i.e., as intertwined
molecular signatures containing genes, proteins, mRNAs, and miRNAs, but also epigenomic
characterizations, as well as correlations with microbiomes’ compositions, just to name the major,
able to capture the inter-layers connections and the complexity of phenotypes. This request is
seconded by demands and concerns about the storage and reusability of much of such different
omic data. Indeed, although publicly and freely available, these data often lie in databases and
repositories underutilized or not used at all. Issues coming from lack of standardization and shared
biological identities are also well known to represent a hurdle for data reuse (Tieri and Nardini,
2013; Chowdhury and Sarkar, 2015).
The “Multi-Omic Data Integration” Research Topic is in our intention a dedicated forum to
collect efforts that help in defining this emerging field, aimed to the integration of data, analyses
and approaches from, and for multiple omics.
The articles here collected address these questions from a number of perspectives that
we summarize as experimental, network based, and methodological. In the first category the
authors extract and analyse different types of high-throughput data (epitomics, localisomics,
transcriptomics, lipidomics) from different locations on model organisms [Arabidopsis thaliana
(Wilson et al., 2015) and rhesus macaques (Lee et al., 2014)] to understand a complex biological
question (roots’ growth and response to anti-malarial drugs) that could not be addressed with
single-omic approaches.
We transition from these approaches to more theoretical ones via the usage of graphs. Networks
offer a complete, intuitive, versatile, and powerful approach to the representation of complex
systems (genomics, epigenomics, transcriptomics, metabolomics, host-microbiome interface,
diseases’ phenomics) which is here exploited to represent the multifaceted aspects of complex
autoimmune diseases (rheumatoid arthritis, Tieri et al., 2014) in order to evaluate complex side
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effects of old and novel therapies; to identify disease molecules
that can be both effective therapeutic targets relevant progression
markers with application to diabetic nephropathy (Heinzel et al.,
2014); to stratify patients with comorbidities (Moni and Lio,
2015).
Methodological approaches point with a novel emphasis at
the importance of molecules’ spatial localization in the omic
context. From polysome and ribosome profiling, RNA, and
miRNA binding sites annotation and standardization (Dassi and
Quattrone, 2014), to networks including 3Dmolecules’ proximity
thanks to Chromosome Conformation Capture (3C) and its
omic version Hi-C (Merelli et al., 2015), spatial representation
contributes with an important layer of information in this added
multi-omic complexity.
Beyond spatial organization, temporal progression and causal
inference are discussed to model the heterogeneity of CD4+ T
cells and their complex immune responses (Carbo et al., 2014),
and to predict gene networks based on ChIP-seq and RNA-seq
integration (Angelini and Costa, 2014).
Finally, meta analyses of genomes, be it for the exploration of
microbiomes’ compositions or disease genome-wide association
studies (GWAS) still benefit from discussion in this research
topic, on one side for the need of standardization of the workflow
(Ladoukakis et al., 2014) in a relatively novel research area (omic
microbiology) and on the other side to compensate with multi-
omic layers to the limited statistical power and reproducibility of
GWAS (Lin et al., 2014).
This collection is the tip of an iceberg that continues to grow
and to evolve in multiple directions. From the continuously
improving efficiency of existing high-throughput platforms
that imply easier, cheaper and more frequent spatio-temporal
sampling, to the input of novel technologies that will offer omic
views on novel types of data (phenotypes, tissues, 3D proteins
etc., all entailing the production and approval of dedicated
standards for data storage) we are only at the beginning of almost
endless possibilities of data integration.
However, to avoid getting lost in the sea of data, efficient
algorithms as well as biologically meaningful directions in which
to integrate information will be of importance. This will imply
not only the implementation of powerful tools to give answers,
but also the design of careful approaches to form questions.
We hope and foresee that these needs will foster the
collaboration between biologists, medical doctors, statisticians,
and computer scientists further, transforming the residual
perception of this forced cooperation from a burden to a
resource. The impact of completing this other type of integration
among scientific expertise is difficult to predict at large, but can
easily be assumed as a necessary and crucial starting point for
the effective implementation of personalized medicine, where
patients’ and health practitioners’ needs are translated into
technology and report on systemic markers, offering patients the
possibility to be treated as a whole and not as a mere assemblage
of parts to be “adjusted.”
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